North Growth Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

North Growth Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-158,000	Closed	-$5.78M	–	48
2022 Q4	$5.78M	Hold	158,000	–	–	1.31%	36
2022 Q3	$7.44M	Buy	158,000 +16,000	+11%	+$1.03M	1.86%	26
2022 Q2	$10.2M	Buy	142,000 +33,000	+30%	+$2.41M	2.37%	17
2022 Q1	$8.83M	Buy	109,000 +14,000	+15%	+$1.18M	1.63%	31
2021 Q4	$9.71M	Buy	+95,000	New	+$9.12M	1.61%	28

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

North Growth Management's SYNH Position: Q1 2023 in Review

North Growth Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 158,000 shares — an estimated $5.78M sold.

North Growth Management first reported a position in SYNH in Q4 2021 and held it in 5 quarters. The position peaked at $10.2M in Q2 2022. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

North Growth Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
North Growth Management sold 158,000 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $5.78M.
North Growth Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 5 quarters.
North Growth Management's Syneos Health, Inc. Class A Common Stock position peaked at $10.2M in Q2 2022.
305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on North Growth Management's 13F filing for Q1 2023, filed 3 May 2023.